3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
CNS
1
Interventions
lutetium Lu 177 dotatate
6
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
cabozantinib
3
pembrolizumab
2
olaparib
2
fludarabine
2
X-Rays
2
Phantoms, Imaging
2
Cyclophosphamide
2
tivozanib
1
repotrectinib
1
pazopanib
1
fludarabine phosphate
1
entrectinib
1
belinostat
1
atezolizumab
1
aldesleukin
1
Yttrium-90
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed, Single-Photon
1
Temozolomide
1
Sunitinib
1
Single Photon Emission Computed Tomography Computed Tomography
1
Salts
1
Positron Emission Tomography Computed Tomography
1
PT-100 dipeptide
1
Octreotide
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Quality of Life
×
NET
×
30 days
×
Clear all
No trials found.